1. Home
  2. SURG vs LSTA Comparison

SURG vs LSTA Comparison

Compare SURG & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SurgePays Inc.

SURG

SurgePays Inc.

HOLD

Current Price

$0.50

Market Cap

13.8M

ML Signal

HOLD

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

HOLD

Current Price

$3.19

Market Cap

28.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SURG
LSTA
Founded
2006
1980
Country
United States
United States
Employees
20
N/A
Industry
Advertising
Misc Health and Biotechnology Services
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.8M
28.9M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
SURG
LSTA
Price
$0.50
$3.19
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$5.00
$15.00
AVG Volume (30 Days)
420.1K
31.8K
Earning Date
04-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.42
EPS
N/A
N/A
Revenue
N/A
$35,283,868.00
Revenue This Year
$136.77
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
56.90
52 Week Low
$0.46
$1.81
52 Week High
$3.45
$5.07

Technical Indicators

Market Signals
Indicator
SURG
LSTA
Relative Strength Index (RSI) 38.26 40.29
Support Level $0.48 $3.02
Resistance Level $0.94 $3.41
Average True Range (ATR) 0.05 0.12
MACD 0.00 0.05
Stochastic Oscillator 18.78 46.64

Price Performance

Historical Comparison
SURG
LSTA

About SURG SurgePays Inc.

Surgepays Inc is a wireless and point of sale technology company focused on serving underserved and value-conscious consumers through a combination of retail distribution and digital acquisition channels. It provides mobile connectivity, financial technology services, and transaction processing solutions through an integrated platform that combines wireless services with point of sale software and retail distribution. It enables in-store and online activation of wireless services, prepaid top-ups, and financial transactions, allowing consumers to access essential services in both local and digital environments. Its segments are wireless services or MVNO Telecommunications, platform services or MVNE Enablement Platform (HERO), and wholesale enablement or Comprehensive Platform Services.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: